Gilead re­leas­es an­oth­er round of murky remde­sivir re­sults

A month af­ter the NIH de­clared the first tri­al on remde­sivir in Covid-19 a suc­cess, Gilead is out with new re­sults on their an­tivi­ral. But …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.